AGF Management
NVO icon

AGF Management’s Novo Nordisk NVO Stock Holding History

AGF Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.5M Buy
+92,286
New +$4.25M 0.01% 304

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Markel Group
Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

AGF Management's NVO Position: Q3 2026 in Review

AGF Management opened a new position in Novo Nordisk (NVO) in Q3 2026: 92,286 shares worth $3.5M. The stake represents 0.01% of the portfolio and ranks #304 among its holdings.

696 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • AGF Management held 92,286 shares of Novo Nordisk worth $3.5M as of Q3 2026.
  • Novo Nordisk was a new AGF Management position in Q3 2026.
  • Novo Nordisk made up 0.01% of AGF Management's portfolio in Q3 2026, its #304 holding.
  • 696 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on AGF Management's 13F filing for Q3 2026, filed 3 Nov 2026.